zidovudine has been researched along with Human T-lymphotropic Virus 1 Infection in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 6 (30.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casseb, J; Eslami, M; Ghazvini, K; Karbalaei, M; Keikha, M; Yousefi, B; Yousefi, M | 1 |
| Soriano, V | 1 |
| Tobinai, K; Tsukasaki, K | 1 |
| Bazarbachi, A; Berry, F; Dassouki, Z; de Thé, H; El Hajj, H; Ezzedine, M; Farid, R; Ghantous, A; Ghavamzadeh, A; Hermine, O; Kchour, G; Kooshyar, MM; Mahmoudi, M; Mortada, M; Nasser, R; Rafatpanah, H; Rahimi, H; Rezaee, R; Shirdel, A; Tarhini, M | 1 |
| Chihara, D; Choi, I; Seto, M; Utsunomiya, A | 1 |
| Deligny, C; Donnio, A; Hage, R; Jean-Charles, A; Meniane, JC; Merle, H; Plumelle, Y | 1 |
| Bittencourt, AL; Farré, L; Mota, K; Oliveira, RF | 1 |
| Afonso, PV; Bangham, CR; Dubreuil, G; Estaquier, J; Gessain, A; Hermine, O; Mahieux, R; Mekaouche, M; Moriceau, A; Mortreux, F; Plumelle, Y; Toulza, F; Wattel, E | 1 |
| Bittencourt, AL; de Oliveira, Mde F | 1 |
| Gallo, RC | 2 |
| Balestrieri, E; Macchi, B; Mastino, A | 1 |
| Bazarbachi, A; Farid, R; Hermine, O; Kchour, G; Kooshyar, MM; Mahmoudi, M; Makhoul, NJ; Rafatpanah, H; Rastin, M; Shirdel, A; Tarhini, M; Zalloua, PA | 1 |
| Dalakas, MC | 1 |
| Behm, FG; Broniscer, A; Gill, P; Head, DR; Mandrell, B; Raimondi, SC; Ribeiro, RC; Srinivas, RV | 1 |
| Harrison, LH; Quinn, TC; Schechter, M | 1 |
| Machuca, A; Soriano, V | 1 |
| Desgranges, C; Fillon, S; Gasmi, M; Leriche, K; Neisson-Vernant, C | 1 |
| Hattori, T; Kannagi, M; Maeda, Y; Matsushita, S; Murakami, T; Sagawa, K; Takatsuki, K | 1 |
| Hartung, HP; Heininger, K; Toyka, KV | 1 |
8 review(s) available for zidovudine and Human T-lymphotropic Virus 1 Infection
| Article | Year |
|---|---|
Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection.
Topics: Adult; Antigens, CD; Chronic Disease; CTLA-4 Antigen; Hepatitis A Virus Cellular Receptor 2; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukocytes, Mononuclear; Lymphocyte Activation Gene 3 Protein; Molecular Targeted Therapy; Paraparesis, Tropical Spastic; Programmed Cell Death 1 Receptor; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Receptors, Immunologic; Signal Transduction; Zidovudine | 2020 |
Biology and treatment of HTLV-1 associated T-cell lymphomas.
Topics: Acute Disease; Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Child; Chronic Disease; Clinical Trials as Topic; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Japan; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, T-Cell; Zidovudine | 2013 |
Recent advances in the treatment of adult T-cell leukemia-lymphomas.
Topics: Antibodies, Monoclonal, Humanized; Antiviral Agents; Cell- and Tissue-Based Therapy; Hematopoietic Stem Cell Transplantation; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunotherapy; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Molecular Targeted Therapy; Receptors, CCR4; Reverse Transcriptase Inhibitors; Zidovudine | 2015 |
Cutaneous manifestations associated with HTLV-1 infection.
Topics: Antiviral Agents; Carrier State; Diagnosis, Differential; Drug Resistance, Neoplasm; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Ichthyosis; Immunohistochemistry; Interferon-alpha; Lymphoma, T-Cell; Scabies; Skin; Skin Diseases, Viral; Treponemal Infections; Zidovudine | 2010 |
Research and discovery of the first human cancer virus, HTLV-1.
Topics: Adult; Animals; Antiviral Agents; Arsenic; Cell Proliferation; Cell Transformation, Viral; Host-Pathogen Interactions; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferons; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Transgenic; Viral Proteins; Virus Replication; Zidovudine | 2011 |
Effects of nucleoside-based antiretroviral chemotherapy on human T cell leukaemia/lymphotropic virus type 1 (HTLV-1) infection in vitro.
Topics: Animals; Anti-Retroviral Agents; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Lamivudine; Nucleosides; Zidovudine | 2003 |
Retroviruses and inflammatory myopathies in humans and primates.
Topics: HIV Infections; HTLV-I Infections; Humans; Myositis; Retroviridae; Retroviridae Infections; Zidovudine | 1993 |
[Neuromuscular manifestations of HIV-1 and HTLV-I infections].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adrenal Cortex Hormones; Capsaicin; Carbamazepine; Demyelinating Diseases; Ganciclovir; HIV-1; HTLV-I Infections; Humans; Muscular Diseases; Neuritis; Neuromuscular Diseases; Peripheral Nervous System Diseases; Polyneuropathies; Zidovudine | 1988 |
12 other study(ies) available for zidovudine and Human T-lymphotropic Virus 1 Infection
| Article | Year |
|---|---|
HTLV-1 Infection Still A Neglected Disease
Topics: Epidemics; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Neglected Diseases; Zidovudine | 2018 |
The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
Topics: Adult; Aged; Arsenic Trioxide; Arsenicals; Cytokines; Female; Gene Expression Profiling; HTLV-I Infections; Humans; Immunologic Factors; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Oxides; Prospective Studies; Treatment Outcome; Zidovudine | 2013 |
RETINAL MANIFESTATIONS IN ADULT T-CELL LEUKEMIA/LYMPHOMA RELATED TO INFECTION BY THE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Eye Infections, Viral; Fatal Outcome; Female; Fluorescein Angiography; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Retinal Neoplasms; Retrospective Studies; Reverse Transcriptase Inhibitors; Zidovudine | 2016 |
A dyshidrosis-like variant of adult T-cell leukemia/lymphoma with clinicopathological aspects of mycosis fungoides. A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diabetes Mellitus; Diagnosis, Differential; Doxorubicin; Eczema, Dyshidrotic; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunohistochemistry; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Mycosis Fungoides; Polymerase Chain Reaction; Prednisone; Skin Neoplasms; Vincristine; Zidovudine | 2009 |
Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors.
Topics: Animals; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD8-Positive T-Lymphocytes; Deltaretrovirus Infections; Disease Models, Animal; Drug Therapy, Combination; Female; Histone Deacetylase Inhibitors; HTLV-I Infections; Humans; Male; Monkey Diseases; Papio; Paraparesis, Tropical Spastic; Reverse Transcriptase Inhibitors; Simian T-lymphotropic virus 1; T-Lymphocyte Subsets; Valproic Acid; Viral Load; Zidovudine | 2010 |
Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Iran; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Proviruses; Treatment Outcome; Vascular Endothelial Growth Factor A; Viral Load; Zidovudine | 2007 |
A surprising advance in the treatment of viral leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Gene Products, tax; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Zidovudine | 1995 |
An adolescent with HTLV-I-associated adult T cell leukemia treated with interferon-alfa and zidovudine.
Topics: Adolescent; Antineoplastic Agents; Antiviral Agents; Blotting, Southern; Combined Modality Therapy; Female; Follow-Up Studies; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; HTLV-I Infections; Humans; Interferon-alpha; Leukemia, T-Cell; Zidovudine | 1996 |
Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo.
Topics: Adult; Anti-HIV Agents; Case-Control Studies; CD4 Lymphocyte Count; HIV; HIV Infections; HTLV-I Infections; Humans; Polymerase Chain Reaction; RNA, Viral; Viral Load; Zidovudine | 1997 |
In vivo fluctuation of HTLV-I and HTLV-II proviral load in patients receiving antiretroviral drugs.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Therapy, Combination; Female; HIV-1; HTLV-I Infections; HTLV-II Infections; Human T-lymphotropic virus 1; Human T-lymphotropic virus 2; Humans; Lamivudine; Middle Aged; Proviruses; T-Lymphocytes; Viral Load; Zidovudine | 2000 |
Zidovudine treatment is not associated with HTLV-1 reverse transcriptase gene mutations in HTLV-I/HIV-1 co-infected patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amino Acid Sequence; Anti-HIV Agents; Female; HIV-1; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation; RNA-Directed DNA Polymerase; Virus Replication; Zidovudine | 1997 |
Immunological and virological status of a hemophiliac infected with human T cell lymphotropic virus type 1 and human immunodeficiency virus type 1, and results of therapy.
Topics: Adolescent; Adult; Hemophilia A; Hemophilia B; HIV Infections; HTLV-I Infections; Humans; Zidovudine | 1991 |